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1030Objective: Failure of anastomotic healing is a rare but serious complication of laryngotracheal resection. Treat-
ment options include reoperation, tracheostomy, or T-tube placement. Hyperbaric oxygen therapy (HBOT) is the
delivery of 100% O2 at pressures greater than 1 atm, and has been shown to enhance wound healing after
tracheal resection in animal models. To date, there have been no reports describing its usefulness in humans after
tracheal resection.
Methods: Five consecutive patients with varying degrees of failed anastomotic healing, from necrotic cartilage
to partial separation identified by bronchoscopy were treated with HBOT. HBOT was administered for 90 mi-
nutes via a hyperbaric chamber pressurized to 2 atmwith 100% oxygen. Patients were treated with daily or twice
daily HBOT. Four of 5 patients had buttressing of the anastomosis by strap muscle at the initial surgery.
Results: All patients had evidence of anastomotic healing on bronchoscopy. None of the patients in this series
required tracheostomy, T-tube, or reoperation after initiation of HBOT. On average it took 9.6 days for healing to
occur (5-14 days). The size of the anastomotic defect ranged between 3 and 13 mm. One patient required bilat-
eral tympanostomy tubes for inner ear discomfort and experienced blurry vision as complications of HBOT. One
patient developed tracheal stenosis from granulation tissue that required bronchoscopic debridement.
Conclusions: In select patients with anastomotic complications after tracheal resection, HBOTmay aid in heal-
ing and avoid tracheostomy. Future investigations are necessary to further define the benefits of HBOT in the
management of airway anastomotic complications. (J Thorac Cardiovasc Surg 2014;147:1030-5)Anastomotic separation after tracheal resection and recon-
struction (TRR) is rare, occurring in only 4% of procedures.1
However, anastomotic separation carries significant
morbidity and a 0.6% chance of mortality.1 Risk factors for
anastomotic complications include diabetes, resection length
greater than 4 cm, reoperation, laryngotracheal resections,
age less than 17 years, and preoperative tracheostomy.1 We
have previously described our experience with anastomotic
complications after TRR. Treatment of anastomotic compli-
cations included reoperation, revision of the anastomosis,
and T-tube or tracheostomy placement.1
Hyperbaric oxygen therapy (HBOT) is the administration
of 100% oxygen at pressures greater than 1 atm. It is
currently used to increase healing of diabetic lower extremity
wounds and radiation injuries. HBOT is believed to promote
wound healing by increasing angiogenesis and collagene General Thoracic Surgical Unit, Department of Surgery, Massachusetts
ral Hospital, Harvard Medical School, Boston, Mass.
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The Journal of Thoracic and Cardiovascular Sursynthesis.2 Recent experimental evidence in animals has
shown that it may stimulate increased healing of the trachea
after resection and reconstruction.3,4 We used HBOT in 5
consecutive patients with anastomotic complications after
tracheal resection and followed their clinical outcomes.
METHODS
This is a retrospective review of 5 consecutive patients treated at a single
institution from 2009 to 2012. Approval for this study was obtained from
the Institutional Review Board. Each patient previously underwent a
tracheal resection and anastomosis and was found to have evidence of
failed anastomotic healing on bronchoscopic examination between postop-
erative days 5 and 7. Our technique for tracheal and laryngotracheal resec-
tion has been described in previous publications.5-8 Bronchoscopic findings
ranged from necrotic cartilage to partial separation of the tracheal
anastomosis. All patients were treated as inpatients and HBOT was
administered for 90 minutes via a hyperbaric chamber pressurized to 2
atm with 100% oxygen. The goal number of HBOT treatments was 20.
Initially in our series, patients were treated with daily HBOT, however
later patients received twice daily HBOT. Four of 5 patients in this series
had careful buttressing of the primary anastomosis with sternohyoid and
sternothyroid strap muscles. One patient with anastomotic separation did
not undergo buttressing of the anastomosis with muscle and underwent
reexploration, revision of the anastomosis, and tracheostomy placement.
In this patient, HBOT was started after the reoperation procedure. All
patients received intravenous broad-spectrum antibiotics and 3 of 5 patients
also received treatment with tobramycin nebulizers administered twice
daily. Heliox was used in patients as clinically indicated.
RESULTS
The characteristics of the patients in this series were as
follows: the mean age was 46 years (range, 20-63 years),gery c March 2014
Abbreviations and Acronyms
CT ¼ computed tomography
HBOT ¼ hyperbaric oxygen therapy
POD ¼ postoperative day
TRR ¼ tracheal resection and reconstruction
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M3 patients had idiopathic tracheal stenosis, 2 patients had
postintubation tracheal stenosis, 3 patients were female,
and 1 patient was a reoperation (Table 1). Two patients
with anastomotic complications in this series had dia-
betes and 1 had a preoperative tracheostomy (Table 1).
The clinical presentation of anastomotic complications
varied (Table 2). Two patients had cervical erythema, 3
patients presented with subcutaneous air, 1 had fever, 2
had leukocytosis, 1 had stridor, and 1 had hemoptysis.
Overall, 4 patients had 2 or more clinical symptoms at
the time the anastomotic complication was recognized.
On bronchoscopic examination, all the patients had evi-
dence of necrosis at the anastomotic site. Three patients
had defects of the anterior cartilage; 2 patients had necrosis
at the lateral cartilaginous aspect of the anastomosis. The
range in size of the anastomotic defect was estimated to
be between 3 and 13 mm (Table 2). Two patients had a sig-
nificant separation of the anastomosis visible on bronchos-
copy (Table 2). Two patients had positive bacterial cultures,
the other 3 patients either did not have cultures or their
tracheal cultures demonstrated normal respiratory flora
(Table 2).
At the time of discharge, all patients underwent bron-
choscopy and had evidence of anastomotic healing. None
of the patients in this series required reoperation after initi-
ation of HBOT. On average it took 9.6 days for healing to
occur (range, 5-14 days) (Table 3). The mean number of
HBOT sessions was 13.2 (range, 5-21) administered either
daily or twice daily (Table 3). Patients in this series had on
average 2.6 bronchoscopies (range, 1-4) performed after the
initiation of HBOT and before discharge (Table 3). The
mean interval between bronchoscopies was 5 days (range,
3-8 days) (Table 3). The average length of stay was 22
days (range, 15-31 days) (Table 4).
Outcomes are listed in Table 4. There were no postoper-
ative deaths. Complications were minor and included 1 pa-
tient who required bilateral tympanostomy tubes for inner
ear discomfort. The same patient also experienced tempo-
rary blurry vision after receiving HBOT. Both of these com-
plications resolved. Three patients developed granulation
tissue at the anastomosis with 1 patient requiring 2 broncho-
scopic debridements. At follow-up, ranging from 1 to 3.5
years, all patients remain asymptomatic and none have
required subsequent dilation or persistent need to treat gran-
ulation tissue.The Journal of Thoracic and CarCase 1
The patient was a 52-year-old man with obesity, diabetes,
coronary artery disease, gastroesophageal reflux disease,
and fibromyalgia who required a tracheostomy in February
2009 after undergoing multiple nasal and pharyngeal proce-
dures for obstructive sleep apnea. The tracheostomy site
was complicated by recurrent infections. He was decannu-
lated in May 2009. He subsequently developed stenosis at
the site of his tracheostomy stoma and was referred for
definitive resection and reconstruction after undergoing 2
failed dilation procedures. He had a 3-cm long stenosis 3
cm below the vocal cords.
TRR was performed through a collar incision with the
addition of a partial sternotomy through the manubrium to
aid in exposure. The anastomosis was to the cricoid carti-
lage and a sternohyoid muscle flap was used to buttress
the anastomosis. Postoperatively, the patient did well until
postoperative day (POD) 7 when he developed erythema
of the neck in addition to leukocytosis. He was placed on
broad-spectrum antibiotics. Bronchoscopy was performed
and persistent necrosis of the anterior cartilage at the anas-
tomosis was observed. A repeat bronchoscopy on POD 14
revealed progression of the necrosis and visualization of
the strap muscle buttress. Frank dehiscence of the anasto-
mosis did not occur. HBOT was started that day after a
computed tomography (CT) scan of the neck did not reveal
subcutaneous air, abscess, or fluid collection. He completed
6 sessions of HBOT between POD 14 and 20. On POD 21,
bronchoscopic examination demonstrated granulation tis-
sue and a gathering of sutures at the anastomosis. The
airway was intact, and the patient was otherwise doing
well. Bronchoscopic debridement of the sutures and granu-
lation tissue was undertaken on POD 27 and POD 31. He
was discharged on POD 32. The patient remains asymptom-
atic 3.5 years later with mild stenosis (20%) on broncho-
scopic examination.Case 2
The patient was a 20-year-old man who developed
tracheal stenosis after tracheostomy after a motor vehicle
accident. In March 2010, he underwent a tracheal recon-
struction with an auricular cartilage graft and T-tube place-
ment. The T-tube was removed but after 5 weeks, a large
amount of scar and granulation tissue was noted on bron-
choscopy. A tracheostomy was placed and he was referred
to our institution 8 months later when it was evident that
the graft had failed. Radiologic and bronchoscopic findings
revealed a 3.5-cm long narrowing that started 1.5 cm below
the vocal cords. Tracheal resection was performed through a
midline neck incision with cricotracheal anastomosis and
sternohyoid muscle flap coverage.
On POD 7, bronchoscopy revealed a 3-mm region of sep-
aration and necrotic cartilage at the anterior anastomosis. Adiovascular Surgery c Volume 147, Number 3 1031
TABLE 1. Patient characteristics
Characteristic Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Diagnosis PITS PITS Idiopathic Idiopathic Idiopathic
Age (y) 52 20 63 45 52
Sex M M F F F
Reoperation No Yes No No No
Diabetes Yes No Yes No No
Preoperative
tracheostomy
No Yes No No No
Reoperation No Yes No No No
Postoperative
tracheostomy
No No No No No
Laryngotracheal
resection
No No Yes Yes Yes
PITS, Postintubation tracheal stenosis.
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MGram stain taken from the anastomosis demonstrated gram-
negative and gram-positive organisms, however the culture
ultimately revealed normal respiratory flora. The patient
was placed on inhaled tobramycin and HBOTwas initiated.
He completed 20 sessions between POD 8 and 21. Three
subsequent bronchoscopies on POD 10, 14, and 20 showed
gradual anastomotic healing. There was no purulent mate-
rial present at the anastomosis after starting HBOT, and su-
tures that were visible on previous bronchoscopies became
covered with healthy granulation tissue. He was discharged
on POD 23. At 1-month follow-up, the anastomosis was
well healed with only a 10% narrowing as a result of scar
tissue. The patient remains asymptomatic in follow-up.Case 3
The patient was a 63-year-old woman with diabetes, hy-
pertension, hyperlipidemia, and depression who developed
idiopathic subglottic stenosis. She had undergone multiple
tracheal dilation procedures with little relief from her
symptoms. A laryngotracheal resection was performed
through a transverse collar incision below the cricoid andTABLE 2. Presenting symptoms and bronchoscopic findings
Finding Patient 1 Patient 2
Cervical erythema Yes Yes
Subcutaneous emphysema No No
Fever No No
Leukocytosis Yes No
Stridor No No
Postoperative hemoptysis No Yes
Location of defect(s) Anterior Anterior
Size of defect(s) (mm) 10 3
Exudate Yes No
Culture Enterococcus faecalis Normal flor
Edema No No
Erythema Yes Yes
Necrosis or ischemia Yes Yes
Separation No Yes
1032 The Journal of Thoracic and Cardiovascular Surcricotracheal anastomosis was performed. Bronchoscopy
performed on POD 6 revealed a widely patent, intact anas-
tomosis with minimal vocal cord edema and minimal sub-
glottic swelling. She was discharged home that day but
returned on POD 7 with swelling and palpable subcutane-
ous emphysema in her neck. A CT scan demonstrated sig-
nificant subcutaneous air tracking from the anastomosis to
the lateral neck. A bronchoscopy performed the following
day revealed a larger than expected area of anterior necrosis
with anastomotic separation and visualization of the sur-
rounding soft tissue. Based on these findings, she underwent
neck reexploration whereby necrosis of the anterior por-
tions of the first 2 rings was found. These were debrided
leaving the lateral and posterior aspects of the anastomosis
intact. The distal trachea was mobilized and the anterior
portion was sutured to the thyroid cartilage. Strap muscles
were used to cover the anastomosis and a tracheostomy
was placed for airway protection. Cultures of the necrotic
airway were positive for Eikenella corrodens. She subse-
quently completed 5 treatments of HBOT between POD
12 and 16.
Bronchoscopy was performed on POD 16 and showed
moderate subglottic swelling but otherwise no necrosis or
separation. The patient was discharged on POD 20. Her tra-
cheostomy was successfully removed 1 month later and the
patient has been free of complications since.
Case 4
The patient was a 45-year-old woman who was diag-
nosed with idiopathic subglottic stenosis after an 8-year his-
tory of shortness of breath on exertion. Her medical history
also included hypertension and anxiety. She underwent 2
rigid bronchoscopies with tracheal dilation before resection
and reconstruction. When her symptoms failed to improve,
she underwent a TRR with cricotracheal anastomosis in
May 2012. A sternohyoid strap muscle was used to buttress
the anastomosis. On POD 2, the patient developed erythemaPatient 3 Patient 4 Patient 5
No Yes No
Yes Yes Yes
No No Yes
No No Yes
No No Yes
No No No
Anterior Lateral Lateral
10 8 13
No Yes Yes
a Eikenella corrodens — Normal flora
Vocal cords Anastomotic Anastomotic
Yes No No
Yes Yes Yes
Yes No No
gery c March 2014
TABLE 3. Treatment with HBOT
Treatment details Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Total sessions 6 20 5 14 21
Number of days 6 14 5 10 14
Days until defect
healed
8 12 5 9 14
Subsequent number
of bronchoscopies
3 3 1 2 4
Mean bronchoscopy
interval (d)
5.7 4.3 8 4 3.2
Stock et al Perioperative Managementof the neck and was started on broad-spectrum antibiotics.
She remained afebrile, with a normal white blood cell
count, however the erythema progressed. A CT performed
on POD 5 showed subcutaneous emphysema in the tissues
of the neck and mediastinum (Figure 1). On the following
day, bronchoscopy was performed and she was noted to
have a 5-mm region of exposed cartilage covered with
exudative tissue at the anastomotic site. She was started
on HBOT that day, along with nebulized tobramycin and
intravenous broad-spectrum antibiotics.
The patient completed 14 HBOT sessions between POD
6 and POD 15. Two days after starting HBOT, repeat bron-
choscopy showed no exudate, reduced swelling, and evi-
dence of healthy granulation starting to form at the
anastomosis. By POD 9, both the erythema and subcutane-
ous emphysema had resolved. A bronchoscopy on POD 14
showed a well-healed, completely granulated anastomosis
with minimal swelling. She was discharged home on POD
15. She remains asymptomatic 1 year later.P
MCase 5
The patient was a 62-year-old woman who presented
with a 4-year history of shortness of breath caused by idio-
pathic subglottic stenosis. Multiple laser dilation proce-
dures failed. She underwent laryngotracheal resection and
reconstruction with posterior membranous tracheal wall
flap and a sternohyoid muscle flap.
On POD 4, the patient developed a change in her breath-
ing believed to be a result of laryngeal edema. She re-
sponded to a 24-hour course of steroids, but her breathing
did not return to baseline. Bronchoscopy on POD 7 showedTABLE 4. Outcomes
Outcome
Follow-up (y)
Granulation at the anastomosis
Anastomotic stenosis requiring reintervention
Separation of anastomosis that required either airway appliance or reoperation
Length of stay (d)
Postoperative death
The Journal of Thoracic and Carnecrotic cartilage with a white exudate, 2 visible sutures,
and a small 2- to 3-mm extraluminal cavity (Figure 1).
She was immediately started on twice daily HBOT and
nebulized tobramycin. Sputum cultures grew normal respi-
ratory flora.
Bronchoscopy performed on POD 9 showed slight
improvement in the appearance of the anastomosis, how-
ever exposed cartilage on the right side and 2 traction su-
tures were still visible. The rest of the airway appeared
intact. On POD 14, the previously identified cavity at
the anastomosis had been filled with healthy granulation
tissue. There was also a significant decrease in the amount
of exudate and there was new vascularized granulation tis-
sue present. The patient developed inner ear discomfort
during HBOT for which she had tympanostomy tubes
placed on POD 12 and her HBOT regimen was changed
to once daily. In total, she had 21 sessions between
POD4 and POD 21.
A final bronchoscopy was done on POD 21 and showed
that the area of necrosis had completely filled in with heal-
ing tissue. She was discharged on POD 21 and her tympa-
nostomy tubes were discontinued. A bronchoscopy 28
days after her discharge on POD 48 demonstrated that the
area of necrosis was completely healed. A small nodule
of granulation tissue with mucosa covering it was noted,
but there was no significant airway narrowing (Figure 1).
She has remained asymptomatic at follow-up 1 year postop-
eratively. She previously had complained of blurry vision,
which resolved 3 weeks after stopping HBOT.DISCUSSION
We have previously reported our experience with anasto-
motic complications after tracheal resection.1 Our usual
practice for patients with necrosis or separation of the anas-
tomosis was to place a tracheostomy or T-tube or, in select
cases, perform a revision of the anastomosis. In this study,
we describe our initial experience using HBOT for the treat-
ment of anastomotic complications after tracheal resection.
To our knowledge, this is the first study to use HBOT in hu-
mans to promote tracheal healing.
Failure of anastomotic healing after TRR can result in
catastrophic outcomes.1,5 When confronted with such a
complication, a secure airway must be established.Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
3.5 2 1.5 1 1
Yes No Yes No Yes
Yes No No No No
No No Yes No No
31 23 20 15 21
No No No No No
diovascular Surgery c Volume 147, Number 3 1033
FIGURE 1. Bronchoscopy and computed tomography (CT) findings at
initiation of hyperbaric oxygen therapy (HBOT) and after completion of
treatment. A, Axial CTof the neck demonstrating significant subcutaneous
air. B, Bronchoscopy after initiation of HBOT treatment. Note the presence
of necrosis and visible suture material at the lateral aspect of the anasto-
mosis. C, Bronchoscopy after completing 21 HBOT sessions at 48 days
postoperatively. Complete healing of the anastomosis is evident. A small
granuloma at the lateral aspect was noted that did not require intervention.
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MBronchoscopy and axial CT are essential to evaluate the
airway. Patients should be accompanied by qualified
medical personnel to radiology or HBOT treatments.1034 The Journal of Thoracic and Cardiovascular SurPatients should also be cared for in the intensive care
setting until confident that the airway is stable.
The application of HBOT increases the partial pressure of
oxygen in healing tissue.9 It has been shown in randomized
studies to increase the rate of healing in diabetic ulcers and
prevent amputation in this patient population.9,10 Two
recent studies in rats demonstrated that, after tracheal
resection, animals treated with HBOT had increased rates
of epithelialization, decreased inflammation, and overall
increased anastomotic healing compared with control
rats.3,4
HBOT is believed to improve wound healing through
several mechanisms. HBOT generates reactive oxygen
and nitrogen species, which stimulate angiogenesis by local
endothelial cells and through the activation of circulating
stem/progenitor cells derived from the bone marrow.2
Many growth factors known to be important in angiogenesis
including vascular endothelial growth factor, platelet-
derived growth factor, and hypoxia-inducible factor-1 and
-2 are increased after the administration of HBOT.2,11 In
addition, HBOT has been shown to increase fibroblast
proliferation and collagen production in healing wounds.12
Treatment protocols for HBOT are variable. HBOT is
usually administered at 2 to 3 atm once or twice daily for
20 to 40 days. However, some studies have prolonged treat-
ment for up to 8 weeks.10 At our institution, we favored a
target of 20 treatments of HBOT delivered at 2 atm. As
our experience with HBOT increased, we increased the fre-
quency from daily treatments to twice daily treatments to
reduce the duration of therapy. In our study, the average
number of treatments received was 13.2. HBOTwas discon-
tinued when patients showed signs of significant anasto-
motic healing on bronchoscopy regardless of the number
of treatments they had received.
Our results are significant in that reoperation or a perma-
nent tracheostomy was avoided in all patients treated with
HBOT. The exception to this is the patient who underwent
revision of the anastomosis and tracheostomy placement
before the initiation of HBOT. Significantly, this patient
did not undergo buttressing of the anastomosis with strap
muscle at the time of the initial operation. We routinely
perform a muscle flap on most of our tracheal anastomoses
and believe that the use of a muscle buttress is essential for a
successful outcome with HBOT. A strap muscle buttress
acts to seal the anastomosis when necrosis or separation oc-
curs, preventing free communication between the tracheal
lumen and the surrounding soft tissues. Also, the muscle
flap provides additional blood supply and may work in con-
cert with HBOT by providing a bed of relatively well-
vascularized tissue on which to form granulation tissue.
Antibiotic therapy is also an important aspect in the man-
agement of these patients. Two of the 5 patients in this series
had a documented infection with a pathologic organism.We
favor obtaining cultures and starting broad-spectrumgery c March 2014
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Mantibiotics in all patients who present with anastomotic dis-
ruptions after TRR. As a result of our experience with the
lung transplant population, we began using inhaled tobra-
mycin in patients being treated with HBOT for tracheal
complications. Previously, inhaled tobramycin has been
shown to improve tracheobronchial healing in patients
with tracheobronchial anastomoses.13 It has been suggested
that this is the result of decreased bacterial burden during
the period of early ischemia after tracheobronchial anasto-
mosis.13 There are too few patients in this series to compare
the outcomes of patients who received inhaled tobramycin
and those who did not.
Complications as a result of HBOT treatment are rare.
The most common complication is ear pain occurring in
17% of patients in 1 series.14 Rarely, oxygen toxicity result-
ing in grand mal seizures occurs.14 Progressive myopia and
cataract formation have also been reported.15,16 In this
series, the number of complications were low and were
minor. One patient developed blurry vision and required
temporary bilateral tympanostomy tubes for ear pain. No
deaths were observed. Three of the 5 patients developed
granulation tissue at the anastomosis. However,
bronchoscopic debridement was required in only 1
patient. Our initial experience with HBOT therefore
demonstrates that it seems to promote tracheal healing
without formation of exuberant granulation tissue.
This study describes our initial experience with HBOT
for tracheal anastomotic complications. Without a larger
number of patients and randomization, it is difficult to quan-
tify the effect of HBOT, however compared with our previ-
ous experience managing anastomotic complications, we
have observed a significantly decreased time course for
healing to occur when patients are treated with HBOT. Pre-
viously, when anastomotic complications have been
observed, we have been aggressive about securing the
airway; all patients have undergone an intervention with
either a T-tube, tracheostomy, or reoperation. Therefore,
we cannot compare our outcomes with HBOTwith the out-
comes of a cohort treated with observation alone.
Future investigations are required to delineate the benefit
of HBOT in the management of airway anastomotic compli-
cations. Other complications of thoracic surgery may be
amenable to HBOT, such as anastomotic complications af-
ter lung transplantation, bronchoplastic procedures, or
bronchopleural fistulas. The optimum number of treat-
ments, duration of treatment, twice daily versus daily treat-
ments will also need to be evaluated and standardized in the
future.The Journal of Thoracic and CarCONCLUSIONS
HBOT may be effective in managing postoperative anas-
tomotic complications after TRR. Inhaled nebulized tobra-
mycin and intravenous antibiotics are believed to be
important to avoid infectious complications of necrotic
cartilage. Heliox should be considered if any difficulty in
breathing is encountered. HBOT should be considered in
managing airway complications after other bronchoplastic
procedures or even in lung transplant patients with anasto-
motic complications. All patients must be carefully fol-
lowed with CT scans and bronchoscopy to identify
possible anastomotic dehiscence.
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